License and Distribution Agreements (Details Narrative) - USD ($) $ in Thousands					3 Months Ended	12 Months Ended
	Dec. 11, 2023	Aug. 25, 2023	Jul. 31, 2023	Mar. 17, 2023	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023
Deferred Revenue					$ 5,061	$ 5,061
Issuance of common stock						6,000
Purchase and sale of shares			857,142
Common Stock [Member]
Issuance of common stock
Purchase and sale of shares						2,141,098
Regeneron Research Collaboration Services Agreement [Member]
Nonrefundable up-front payment		$ 750
Service agreement term		5 years
License agreement notice period		30 days
Regeneron Services Agreement [Member]
Received payments						$ 1,325
Revenues					688
Deferred Revenue					$ 637	$ 637
Pulthera LLC Binding Term Sheet [Member]
Payment of option fee in cash							$ 3,000
Pulthera LLC Binding Term Sheet [Member] | Research and Development Expense [Member]
Option fee expense				$ 3,000
Pulthera LLC Binding Term Sheet [Member] | Common Stock [Member]
Issuance of common stock							$ 1,000
Purchase and sale of shares				169,492
License Agreement With Biocellgraft Inc [Member]
Commercial license	4 years
Commercial license to dental products agreement renewal term	2 years
License fee expense	$ 5,000
License fees payment period	2 years
License fee payment	$ 300
Additional license fee	$ 300